Lifecore Biomedical Inc
NASDAQ:LFCR
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
259.3m USD |
Loading...
|
|
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY |
Loading...
|
|
| CH |
|
Nestle SA
SIX:NESN
|
199.2B CHF |
Loading...
|
|
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
79.3B USD |
Loading...
|
|
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
57B ZAR |
Loading...
|
|
| FR |
|
Danone SA
PAR:BN
|
46.5B EUR |
Loading...
|
|
| US |
|
Hershey Co
NYSE:HSY
|
46.2B USD |
Loading...
|
|
| ZA |
A
|
Avi Ltd
JSE:AVI
|
37.2B ZAR |
Loading...
|
|
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
28.2B CHF |
Loading...
|
|
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
248.8B CNY |
Loading...
|
|
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
210.6B CNY |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Lifecore Biomedical Inc is 31.6%, which is above its 3-year median of 30.2%.
Over the last 3 years, Lifecore Biomedical Inc’s Gross Margin has increased from 28% to 31.6%. During this period, it reached a low of 24.6% on Feb 26, 2023 and a high of 34.9% on Nov 24, 2024.
